Transplantation, AutologousBone Marrow TransplantationHematopoietic Stem Cell TransplantationStem Cell TransplantationPeripheral Blood Stem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsTransplantation, HomologousCombined Modality TherapyCyclophosphamideTransplantation ConditioningTreatment OutcomeBone MarrowMultiple MyelomaMelphalanGraft vs Host DiseaseStem CellsSalvage TherapyBone Marrow CellsLymphoma, Non-HodgkinRemission InductionWhole-Body IrradiationDisease-Free SurvivalRecurrenceEtoposideAntineoplastic AgentsBone Marrow PurgingHodgkin DiseaseCytarabineBusulfanSurvival RateCarmustineGraft SurvivalHematopoietic Stem CellsSurvival AnalysisLiver TransplantationHematologic NeoplasmsMyeloablative AgonistsCell TransplantationHematopoietic Stem Cell MobilizationTransplantation ChimeraCell DifferentiationEmbryonic Stem CellsThiotepaTissue DonorsRetrospective StudiesVincristinePrognosisDoxorubicinTime FactorsLeukemiaChemotherapy, AdjuvantFollow-Up StudiesLeukemia, Myeloid, AcuteInduced Pluripotent Stem CellsHistocompatibility TestingKidney TransplantationAnemia, AplasticAntigens, CD34Granulocyte Colony-Stimulating FactorLymphoma, Mantle-CellDexamethasoneHistocompatibilityAntineoplastic Agents, AlkylatingBone and BonesAmyloidosisLymphomaBoronic AcidsPyrazinesLymphoma, FollicularImmunosuppressive AgentsHematopoiesisPluripotent Stem CellsAntibodies, Monoclonal, Murine-DerivedMyelodysplastic SyndromesIfosfamideTransplantation, IsogeneicCells, CulturedMesenchymal Stem Cell TransplantationLeukemia, MyeloidNeoplasm, ResidualPrednisonePodophyllotoxinCell SeparationPrecursor Cell Lymphoblastic Leukemia-LymphomaCord Blood Stem Cell TransplantationInduction ChemotherapyLeukapheresisLymphoma, T-Cell, PeripheralThalidomideAutograftsAcute DiseaseGraft RejectionTransplantation ImmunologyDose-Response Relationship, DrugHepatic Veno-Occlusive DiseaseHeart TransplantationCell Culture TechniquesCisplatinProspective StudiesLeukemia, Myelogenous, Chronic, BCR-ABL Positive